Liver Transplantation for Primary Biliary Cholangitis.

Area of Science:

• Hepatology
• Transplant Surgery
• Immunology

Background:

• Liver transplantation (LT) volumes have risen significantly over 30 years.
• Primary biliary cholangitis (PBC) is now an infrequent indication for LT.
• Improved early diagnosis and ursodeoxycholic acid (UDCA) treatment have reduced the need for LT in PBC.

Purpose of the Study:

• To analyze the current role and outcomes of liver transplantation for primary biliary cholangitis.
• To highlight the effectiveness of LT as a curative option for end-stage PBC.
• To identify risks and management considerations for PBC patients post-LT.

Main Methods:

• Retrospective analysis of liver transplant data.
• Review of patient survival rates and indications for LT.
• Assessment of post-transplant outcomes, including rejection and recurrence rates.

Main Results:

• Despite increased overall LT rates, PBC is an uncommon indication.
• LT provides excellent survival rates for patients with progressive PBC unresponsive to medical therapy.
• PBC patients undergoing LT face elevated risks of graft rejection and disease recurrence.

Conclusions:

• Liver transplantation remains a vital, high-survival option for end-stage primary biliary cholangitis.
• Effective medical management has decreased the incidence of PBC as an LT indication.
• Vigilant post-transplant surveillance is crucial for managing PBC recurrence and rejection risks.